Results 181 to 190 of about 11,040,705 (306)
Objective To support high‐quality, patient‐centered care for systemic lupus erythematosus (SLE), the American College of Rheumatology (ACR) developed evidence‐based measures incorporating clinical and patient‐reported outcome measures (PROMs). Using the Consolidated Framework for Implementation Research (CFIR), we conducted semistructured interviews ...
Catherine Nasrallah +13 more
wiley +1 more source
An enhanced energy management framework based on artificial gorilla troops for optimal operation of grid-connected multi-nanogrids. [PDF]
Elsayed WT +4 more
europepmc +1 more source
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Comparative analysis of marginal profit between da Vinci SP and multi-port systems in colorectal cancer surgery: a single-center descriptive cost-accounting study. [PDF]
Deguchi K, Hirano Y.
europepmc +1 more source
Objective Cam morphology, a significant risk factor for hip osteoarthritis, is commonly quantified by the alpha angle (AA). This study aims to explore the potential of the triangular index ratio (TIR) to quantify cam morphology on anteroposterior radiographs by assessing the association between TIR‐defined cam morphology and the development of ...
Jinchi Tang +7 more
wiley +1 more source
Economic evaluation of ponatinib vs reference and generic imatinib in front-line management of philadelphia chromosome-positive acute lymphoblastic leukemia: A value dilemma. [PDF]
Amamoo RS +5 more
europepmc +1 more source
The influence of open plan work-environments on the productivity of employees: the case of engineering firms in Cape Town [PDF]
Wildré Kok +4 more
doaj
Cost/page and cost/page/impact factor data for selected mathematics journals. [PDF]
Roth, Dana L.
core
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source

